Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Joseph F. Merola
802  Ergebnisse:
Personensuche X
?
1

Rapid response of refractory subacute cutaneous lupus after..:

Gaffney, Rebecca G. ; Merola, Joseph F.
JAAD Case Reports.  44 (2024)  - p. 71-73 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Durable control of psoriatic arthritis with guselkumab acro..:

Ritchlin, Christopher T. ; Mease, Philip J. ; Boehncke, Wolf-Henning...
Clinical Rheumatology.  43 (2024)  8 - p. 2551-2563 , 2024
Link: https://doi.org/10.1007/..
 
?
3

P171 Bimekizumab impact on core group for research and asse..:

Merola, Joseph F ; Mease, Philip J ; Deodhar, Atul...
Rheumatology.  63 (2024)  Supplement_1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
4

The Efficacy and Safety of Bimekizumab for Plaque Psoriasis..:

Burshtein, Joshua ; Shah, Milaan ; Zakria, Danny...
Dermatology and Therapy.  14 (2024)  2 - p. 323-339 , 2024
Link: https://doi.org/10.1007/..
 
?
5

Generalized pustular psoriasis: A consensus statement from ..:

Armstrong, April W. ; Elston, Carly A. ; Elewski, Boni E....
Journal of the American Academy of Dermatology.  90 (2024)  4 - p. 727-730 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Treatment of recalcitrant lupus erythematosus tumidus with ..:

Zhang, Arianna ; Gaffney, Rebecca G. ; Merola, Joseph F.
JAAD Case Reports.  45 (2024)  - p. 110-112 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Prevalence and Impact of Unacceptable Symptom State among P..:

Zundell, Melissa P. ; Ogdie-Beatty, Alexis R. ; Perez-Chada, Lourdes...
JID Innovations.  4 (2024)  5 - p. 100292 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Impact of Oral, Selective, Allosteric Tyrosine Kinase 2 Inh..:

Gottlieb, Alice B. ; Armstrong, April W. ; Merola, Joseph F....
SKIN The Journal of Cutaneous Medicine.  8 (2024)  2 - p. s383 , 2024
Link: https://doi.org/10.25251..
 
?
9

Deucravacitinib in Moderate Plaque Psoriasis: Efficacy in t..:

Blauvelt, Andrew ; Korman, Neil J. ; Merola, Joseph F....
SKIN The Journal of Cutaneous Medicine.  8 (2024)  2 - p. s364 , 2024
Link: https://doi.org/10.25251..
 
?
10

Anifrolumab for the treatment of refractory chilblain lupus..:

Woodbury, Michael J. ; Smith, Katherine Nabel ; Smith, Jeffrey S..
JAAD Case Reports.  48 (2024)  - p. 69-71 , 2024
Link: https://doi.org/10.1016/..
 
?
11

E067 Bimekizumab maintained efficacy responses through 52 w..:

Tillett, William R ; Merola, Joseph F ; Tanaka, Yoshiya...
Rheumatology.  63 (2024)  Supplement_1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
12

Efficacy and safety of guselkumab in patients with active p..:

Ogdie, Alexis ; Merola, Joseph F. ; Mease, Philip J....
BMC Rheumatology.  8 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
13

Association of the clinical components in the distal interp..:

McGonagle, Dennis ; Kavanaugh, Arthur ; McInnes, Iain B...
Rheumatology.  , 2024
Link: https://doi.org/10.1093/..
 
?
14

E069 Bimekizumab maintained efficacy responses through 52 w..:

Tillett, William R ; Merola, Joseph F ; Tanaka, Yoshiya...
Rheumatology.  63 (2024)  Supplement_1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
15

The Impact of Lebrikizumab on Vaccine-Induced Immune Respon..:

Soung, Jennifer ; Laquer, Vivian ; Merola, Joseph F....
Dermatology and Therapy.  , 2024
Link: https://doi.org/10.1007/..
 
1-15